Merck KGaA (MKGAF)

Market Cap	65.28B
Revenue (ttm)	24.96B
Net Income (ttm)	3.47B
Shares Out	n/a
EPS (ttm)	7.98
PE Ratio	18.82
Forward PE	14.97
Dividend	2.50 (1.67%)
Ex-Dividend Date	Apr 28, 2025

Volume	357
Average Volume	428
Open	151.81
Previous Close	152.25
Day's Range	147.66 - 152.25
52-Week Range	118.05 - 159.75
Beta	0.73
RSI	55.88
Earnings Date	Mar 5, 2026

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables, devices, instruments, software, and services for research, production, and testing; process solutions consisting of filtration devices, chromatography...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1668
• Employees: 62,346
• Stock Exchange: OTCMKTS
• Ticker Symbol: MKGAF

Financial Performance

In 2024, Merck KGaA's revenue was 21.16 billion, an increase of 0.78% compared to the previous year's 20.99 billion. Earnings were 2.78 billion, a decrease of -1.66%.

Financial numbers in EUR